发明授权
US07220743B2 Heterocyclic CB1 receptor antagonists 失效
杂环CB1受体拮抗剂

Heterocyclic CB1 receptor antagonists
摘要:
The present invention relates to compounds of formula wherein R1 and R2 are each independently hydrogen or halogen. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
公开/授权文献
信息查询
0/0